These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15608675)

  • 1. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
    Belguise K; Kersual N; Galtier F; Chalbos D
    Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
    Milde-Langosch K; Janke S; Wagner I; Schröder C; Streichert T; Bamberger AM; Jänicke F; Löning T
    Breast Cancer Res Treat; 2008 Feb; 107(3):337-47. PubMed ID: 17393299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fos-related antigen 1 modulates malignant features of glioma cells.
    Debinski W; Gibo DM
    Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo.
    Adiseshaiah P; Lindner DJ; Kalvakolanu DV; Reddy SP
    Cancer Res; 2007 Jul; 67(13):6204-11. PubMed ID: 17616677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
    Schröder C; Schumacher U; Müller V; Wirtz RM; Streichert T; Richter U; Wicklein D; Milde-Langosch K
    Eur J Cancer; 2010 Jun; 46(9):1650-60. PubMed ID: 20226654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
    Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
    Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
    Wang XY; Tan JX; Vasse M; Delpech B; Ren GS
    Chin Med J (Engl); 2009 Jun; 122(11):1300-4. PubMed ID: 19567141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
    Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
    Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
    Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells.
    Kattan Z; Minig V; Leroy P; Dauça M; Becuwe P
    Breast Cancer Res Treat; 2008 Mar; 108(2):203-15. PubMed ID: 17473980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene.
    Song Y; Qian L; Song S; Chen L; Zhang Y; Yuan G; Zhang H; Xia Q; Hu M; Yu M; Shi M; Jiang Z; Guo N
    Mol Immunol; 2008 Jan; 45(1):137-43. PubMed ID: 17572495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].
    Hou YF; Yuan ST; Li HC; Wu J; Lu JS; Lu LJ; Liu G; Shen ZZ; Ding J; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):389-92. PubMed ID: 16188119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.
    Sommers CL; Thompson EW; Torri JA; Kemler R; Gelmann EP; Byers SW
    Cell Growth Differ; 1991 Aug; 2(8):365-72. PubMed ID: 1793731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
    Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
    Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.